AI assistant
Sending…
Evogene Ltd. — Board/Management Information 2016
Dec 29, 2016
6785_rns_2016-12-29_dabb096c-b0a5-42b0-a51c-30497b8cbd2f.htm
Board/Management Information
Open in viewerOpens in your device viewer
_________ false
| ����� ��"� | 2 380 |
| EVOGENE LTD | |
| Corporation no: 512838723 | 10571 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 29/12/2016 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2016-02-145252 | Time of broadcast: 17:02 16:48:54 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on Changes in management |
| Changes_in_management_isa.pdf |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: -1 | Date of revision of form structure: 28/12/2016 |
| Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , Tel: 08-9311900 , Fax: 08-9466724 | |
| E-mail address: [email protected] Company site: www.evogene.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Masliah Sassi Position of Signatory in the reporting corporation: Adv., Corporate Secretary Name of Employer Company: | |
| Address: Eizenberg Aharon 19 , Rehovot 7629008 Telephone: 08-9311971 Facsimile: 08-9466724 E-mail: [email protected] 1 | |
More from Evogene Ltd.
Earnings Release
2026
May 20
Report Publication Announcement
2026
May 20
Foreign Filer Report
2026
May 20
Report Publication Announcement
2026
May 18
Regulatory Filings
2026
May 18
Foreign Filer Report
2026
May 18
Report Publication Announcement
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7